Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan N Sabbagh

Showing results (1-10 of 268) with videos related to

Pageof 27
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
Commentary on "the Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics"Marwan N Sabbagh
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2010
Commentary on "Design of comprehensive Alzheimer's disease centers to address unmet national needs"Marwan N Sabbagh
Neurology and Therapy|July 23, 2017
Editorial Introduction to the Special Issue from the International Symposium on Biomarkers for Alzheimer's Disease and Related DisordersMarwan N Sabbagh
The American Journal of Geriatric Pharmacotherapy|July 21, 2009
Drug development for Alzheimer's disease: where are we now and where are we headed?Marwan N Sabbagh
Neurology and Therapy|November 11, 2016
Editorial IntroductionMarwan N Sabbagh
The Lancet. Neurology|June 13, 2022
The importance of genomics in advancing the diagnosis and treatment of dementiaBoris Decourt, Marwan N Sabbagh
Neurology|July 9, 2008
Detecting Alzheimer disease before it happens: The key to prevention?Joseph Quinn, Marwan N Sabbagh
Drugs & Aging|August 15, 2013
Successes and failures for drugs in late-stage development for Alzheimer's diseaseCamryn Berk, Marwan N Sabbagh
Nature Reviews. Neurology|January 10, 2023
Biomarker-based diagnosis of preclinical Alzheimer disease: time for the clinic?Marwan N Sabbagh, Boris DeCourt
Neurology|January 2, 2008
Interactions of stroke, nonsteroidal anti-inflammatory drugs, and APOE status in dementia riskJoseph Rogers, Marwan N Sabbagh
Pageof 27

Showing results (1-10 of 268) with videos related to

Sort By:
Pageof 27
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
Commentary on "the Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics"Marwan N Sabbagh
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2010
Commentary on "Design of comprehensive Alzheimer's disease centers to address unmet national needs"Marwan N Sabbagh
Neurology and Therapy|July 23, 2017
Editorial Introduction to the Special Issue from the International Symposium on Biomarkers for Alzheimer's Disease and Related DisordersMarwan N Sabbagh
The American Journal of Geriatric Pharmacotherapy|July 21, 2009
Drug development for Alzheimer's disease: where are we now and where are we headed?Marwan N Sabbagh
Neurology and Therapy|November 11, 2016
Editorial IntroductionMarwan N Sabbagh
The Lancet. Neurology|June 13, 2022
The importance of genomics in advancing the diagnosis and treatment of dementiaBoris Decourt, Marwan N Sabbagh
Neurology|July 9, 2008
Detecting Alzheimer disease before it happens: The key to prevention?Joseph Quinn, Marwan N Sabbagh
Drugs & Aging|August 15, 2013
Successes and failures for drugs in late-stage development for Alzheimer's diseaseCamryn Berk, Marwan N Sabbagh
Nature Reviews. Neurology|January 10, 2023
Biomarker-based diagnosis of preclinical Alzheimer disease: time for the clinic?Marwan N Sabbagh, Boris DeCourt
Neurology|January 2, 2008
Interactions of stroke, nonsteroidal anti-inflammatory drugs, and APOE status in dementia riskJoseph Rogers, Marwan N Sabbagh
Pageof 27